Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
News Release
Genex Announces Case Manager Scholarship Award Recipients
WAYNE, Pa.
Workers' Comp
White Paper
Essentials of Return to Work Series
At Enlyte, we understand that a suc
APAX
News Release
Funds advised by Apax Partners acquire GENEX Services
https://www.apax.com/news-views/funds-advised-by-apax-partners-acquire-genex-services/
WorkCompWire
Article
4 For 14 Interview with Ron Skrocki
Workers' Comp
News Release
Genex Wins Communitas Award for Corporate Social Responsibility
WAYNE, Pa. – March 5, 2014 – Genex Services, Inc.
Mitchell
Case Study